Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ReproART is a private reproductive medicine and fertility care provider in Georgia operating under the name ReproART Georgian-American Center for Reproductive Medicine. The company offers assisted reproductive services including in vitro fertilization, intracytoplasmic sperm injection, intrauterine insemination, egg donation, sperm donation, surrogacy coordination, cryopreservation, and preimplantation genetic testing. Its clinical model combines fertility diagnostics, embryology laboratory services, and reproductive genetics for both domestic and international patients. ReproART presents itself as one of the largest IVF centers in Georgia and operates multiple branches across Tbilisi, Kutaisi, and Batumi. The business is a healthcare services organization rather than a drug-development biotech company, with a focus on commercial fertility treatment and reproductive health services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ReproART.